As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Maven Securities LTD, HighTower Advisors LLC, Centiva Capital LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., Valence8 US LP, One River Asset Management LLC, LMR Partners LLP, Gladius Capital Management LP, Mirae Asset Securities USA Inc., Wolverine Asset Management LLC, XY Capital Ltd, SpiderRock Advisors LLC, Genus Capital Management Inc., Caas Capital Management LP, XR Securities LLC, Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, and Capital CS Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.